Eli Lilly's $2.75B Deal Brings AI-Designed Drugs Closer

Pharmaceutical giant Eli Lilly just invested up to $2.

75 billion in AI-powered drug discovery that could revolutionize how we treat diseases.

The partnership with biotech company Insilico Medicine marks one of the largest deals ever for medicines designed entirely by artificial intelligence.